Management of patients with the hereditary long QT syndrome

Journal of Cardiovascular Electrophysiology

Volumn 9, Issue 6, 1998, Pages 668-674

  Moss, Arthur J ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Arrhythmias; Beta blockers; Implantable cardioverter defibrillator; Pacemakers; Sudden death; Syncope; Torsades de pointes

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MEXILETINE; POTASSIUM; SPIRONOLACTONE; TOCAINIDE;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CASE REPORT; DEFIBRILLATOR; ELECTROCARDIOGRAM; FEMALE; GANGLIONECTOMY; GENE THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG QT SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUDDEN DEATH; SYNCOPE; TORSADE DES POINTES;

EID: 0031867358     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1998.tb00952.x     Document Type: Article

References (26)

1. Moss AJ, Schwanz PJ, Crampton RS, et al: The long QT syndrome: Prospective longitudinal study of 328 families. Circulation 1991;84:1136-1144.
2. Vincent GM, Timothy KW, Leppert M, et al: The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N Engl J Med 1992;327:846-852.
3. Jervell A, Lange-Nielsen F: Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957;54:59-68.
4. Romano C, Gemme G, Pongiglione R: Arthmie cardiache rare dell'eta pediatricia: II accessi sincopali per fibrillazione ventricolare parossistica. Clin Pediatr 1963 ;45:656-661.
5. Ward OC: New familial cardiac syndrome in children. J Irish Med Assoc 1964;54:103-106.
6. Wang W, Curran ME, Splawski I, et al: Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996; 12:17-23.
7. Neyroud N, Tesson F, Denjoy I, et al: A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997;15:186-189.
8. Splawski I, Timothy KW, Vincent GM, et al: Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1997;336:1562-1567.
9. Curran ME, Splawski I, Timothy K, et al: A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795-803.
10. McDonald TV, Zhihui Y, Ming Z, et al: A minKHERG complex regulates the cardiac potassium current V Nature 1997;388:289-292.
11. Wang Q, Shen J, Splawski I, et al: SCN5A mutations cause an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-811.
12. Splawski I, Tristani-Firouzi M, Lehmann MH, et al: Mutations in the hminK gene cause long QT syndrome and suppress IKs. Nat Genet 1998; (In press).
13. Schott JJ, Charpentier F, Peltier S, et al: Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 1995;57:1114-1122.
14. Moss AJ, Robinson J: Clinical features of idiopathic long QT syndrome. Circulation 1992;85(Suppl I): 1140-1144.
15. Moss AJ, Zareba W, Benhorin J, et al: Electrocardiographic T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995; 92:2929-2934.
16. Moss AJ: Measurement of the QT interval and the risk associated with QTc interval prolongation: A review. Am J Cardiol 1993;72:23B-25B.
17. Malfatto G, Beria G, Sala S, et al: Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. J Am Coll Cardiol 1994;23:296-301.
18. Moss AJ: Clinical management of patient with the long QT syndrome: Drugs, devices, and gene-specific therapy. PACE 1997;20:2058-2060.
19. Eldar M, Griffin JC, Abbott JA, et al: Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol 1987;10:600-607.
20. Moss AJ, Liu JE, Gottlieb S, et al: Efficacy of permanent pacing in the management of high risk patients with long QT syndrome. Circulation 1991;84:1524-1529.
21. Bhandari AK, Scheinman MM, Morady F, et al: Efficacy of left cardiac sympathectomy in the treatment of patients with the long QT syndrome. Circulation 1984; 70:1018-1023.
22. Schwartz PJ, Locati E, Moss AJ, et al: Left cardiac sympathetic denervation in the therapy of the congenital long QT syndrome: A worldwide report. Circulation 1991;84:503-511.
23. Ouriel K, Moss AJ: Long QT syndrome: An indication for cervicothoracic sympathectomy. Cardiovasc Surg 1995:3:475-478.
24. + channel blockade and to increases in heart rate: Implications for gene-specific therapy. Circulation 1995;92:3381-3386.
25. Rosero SZ, Zareba W, Robinson JL, et al: Gene-specific therapy for long QT syndrome: QT shortening with lidocaine and tocainide in patients with mutation of the sodium channel gene. Ann Noninvas Electrocardiol 1997;2:274-278.
26. Compton SJ, Lux RL, Ramsey MR, et al: Genetically defined therapy of inherited long-QT syndrome: Correction of abnormal repolarization by potassium. Circulation 1996;94:1018-1022.